# HP Halden Pharma AS – FDA Inspection, Nov 17, 2009

Source: https://www.keypedia.com/records/fda_inspections/hp-halden-pharma-as/e4f81252-69b0-4896-9cb6-b07eb70b8122
Source feed: FDA_Inspections

> FDA inspection 631017 of HP Halden Pharma AS, November 17, 2009. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 631017
- Company Name: HP Halden Pharma AS
- Inspection Date: 2009-11-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1205610 - 2023-05-10](https://www.keypedia.com/records/fda_inspections/hp-halden-pharma-as/cae77756-50ae-4839-b796-f28ad76d5024)
- [FDA Inspection 1101303 - 2019-09-03](https://www.keypedia.com/records/fda_inspections/hp-halden-pharma-as/9cb54f53-5d4e-4f5c-93a1-2c26eeb75e27)
- [FDA Inspection 1014636 - 2017-05-26](https://www.keypedia.com/records/fda_inspections/hp-halden-pharma-as/7c786982-397a-49f8-8510-c4470f6f5a87)
- FDA Inspection 931958 - 2015-06-26
- FDA Inspection 863615 - 2013-12-20

Company: https://www.keypedia.com/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
